SCHEMBL8905620

SCHEMBL8905620

COc1ccc(C[C@@H](CBr)C(C)C)cc1OCc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.51
LMNA P02545 2/20 0.51
HTT P42858 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
NPY1R P25929 1/20 0.51
NPY2R P49146 1/20 0.51
KMT2A Q03164 1/20 0.51
BCHE P06276 1/20 0.51
REN P00797 1/20 0.50
ALDH1A1 P00352 1/20 0.50
MAPK1 P28482 1/20 0.50
HSD17B10 Q99714 1/20 0.50
ABCB1 P08183 1/20 0.48
ABCG2 Q9UNQ0 1/20 0.48
SIGMAR1 Q99720 5/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
BLM P54132 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8905614 1.00 KDM4E (0.51) KDM4ELMNAHTTSMN1; SMN2NPY1R
SCHEMBL8906257 0.87 REN (0.46) RENSIGMAR1
SCHEMBL8906253 0.87 REN (0.46) RENSIGMAR1
SCHEMBL30472720 0.82 SIGMAR1 (0.55) KDM4ELMNAHTTSMN1; SMN2NPY1R
SCHEMBL21066487 0.82 SIGMAR1 (0.55) KDM4ELMNAHTTSMN1; SMN2NPY1R
SCHEMBL16930273 0.82 SIGMAR1 (0.55) KDM4ELMNAHTTSMN1; SMN2NPY1R
SCHEMBL3058722 0.81 SIGMAR1 (0.57) KDM4ELMNAHTTSMN1; SMN2NPY1R
SCHEMBL2060386 0.81 MAPK1 (0.63) KDM4ELMNAHTTSMN1; SMN2NPY1R
SCHEMBL4300113 0.81 REN (0.52) REN
SCHEMBL4300111 0.81 REN (0.52) REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5659065-A CHEMICAL INTERMEDIATES FOR MEDICINAL ACTIVE AGENTS NOVARTIS CORPORATION (US) 1997-08-19 US disclosed
EP-0678500-A1 Alpha-amino alkanoic acids and reduction products as intermediates in the preparation of renin inhibitors CIBA-GEIGY AG (CH) 1995-10-25 EP disclosed